council resolut decemb orphan drug council european union regard treati establish european commun resolut novemb integr health protect requir commun polici council consid commun pai attent impact health action propos number area includ free movement good action improv understand address impact human health free movement good free movement medicin product form part commun strategi action field public health diseas small number peopl suffer member state commun step need make easier patient suffer diseas access treatment mean call orphan drug meet criteria medicin rel infrequ diseas natur treatment health econom social effect make advis european context commiss commun novemb framework action field public health singl rare diseas prioriti area commun action decis decemb adopt specif programm research technolog develop includ demonstr field biomedicin health council rare diseas orphan drug specif research area area action includ inventori rare disord commiss commun march outlin industri polici pharmaceut sector european commun refer work undertaken field research biomedicin health orphan drug research commerci viabl drug market low commerci interest major import treatment rare diseas common european approach rare diseas orphan drug hold advantag epidemiolog public health econom term call commiss close cooper member state light guidelin annex situat orphan drug europ make propos view improv access medicin product intend peopl suffer rare diseas annex aspect consid definit orphan drug definit rare diseas regard preval criteria obtain orphan drug statu europ establish condit drug inclus exclus light condit basi classifi measur regulatori provis includ intellectu properti aspect financi incent promot research develop market author distribut orphan drug examin health impact european polici orphan drug member state econom impact european industri